Neon Therapeutics
Cambridge
About Neon Therapeutics
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $161.0M
- Funding stage: M&A
- Last round: Series B (Dec 2017)
- Ticker: nasdaq:NTGN
- Website: neontherapeutics.com
- Phone: (617)337-4701
Industries & Categories
Bioinformatics, Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/neon-therapeutics-2212429 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.